Passage Bio, Inc. · NASDAQ:PASG
Baselake Partners, LP reported a 7.30% stake in Passage Bio, Inc. (Schedule 13G)
Event Jun 18, 2026 · Filed Jun 25, 2026
Baselake Partners, LP reported a 7.30% stake in Passage Bio, Inc., 235,058 shares, as a passive investor on Jun 18, 2026. Filed Jun 25, 2026 (Schedule 13G).
- Stake
- 7.30%
- Shares
- 235,058
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Baselake Partners, LP | 7.30% | 235,058 |
| Baselake Management, LLC | 7.30% | 235,058 |
| David Paolella | 7.30% | 235,058 |